nodes	percent_of_prediction	percent_of_DWPC	metapath
Ethambutol—Optic nerve disorder—Fluorouracil—skin cancer	0.0633	0.0633	CcSEcCtD
Ethambutol—Lung infiltration—Bleomycin—skin cancer	0.0235	0.0235	CcSEcCtD
Ethambutol—Pericarditis—Fluorouracil—skin cancer	0.0198	0.0198	CcSEcCtD
Ethambutol—Gout—Imiquimod—skin cancer	0.0166	0.0166	CcSEcCtD
Ethambutol—Visual acuity reduced—Temozolomide—skin cancer	0.0156	0.0156	CcSEcCtD
Ethambutol—Lymphadenopathy—Imiquimod—skin cancer	0.0132	0.0132	CcSEcCtD
Ethambutol—Hepatic function abnormal—Imiquimod—skin cancer	0.0129	0.0129	CcSEcCtD
Ethambutol—Scotoma—Temozolomide—skin cancer	0.0122	0.0122	CcSEcCtD
Ethambutol—Dermatitis exfoliative—Imiquimod—skin cancer	0.0119	0.0119	CcSEcCtD
Ethambutol—Toxic epidermal necrolysis—Vemurafenib—skin cancer	0.0119	0.0119	CcSEcCtD
Ethambutol—Eosinophilia—Vemurafenib—skin cancer	0.0113	0.0113	CcSEcCtD
Ethambutol—Arthralgia—Vismodegib—skin cancer	0.011	0.011	CcSEcCtD
Ethambutol—Numbness—Fluorouracil—skin cancer	0.0103	0.0103	CcSEcCtD
Ethambutol—Stevens-Johnson syndrome—Vemurafenib—skin cancer	0.0101	0.0101	CcSEcCtD
Ethambutol—Neuropathy peripheral—Vemurafenib—skin cancer	0.00997	0.00997	CcSEcCtD
Ethambutol—Sensory loss—Fluorouracil—skin cancer	0.00989	0.00989	CcSEcCtD
Ethambutol—Musculoskeletal discomfort—Vismodegib—skin cancer	0.00957	0.00957	CcSEcCtD
Ethambutol—Decreased appetite—Vismodegib—skin cancer	0.00913	0.00913	CcSEcCtD
Ethambutol—Disorientation—Bleomycin—skin cancer	0.00894	0.00894	CcSEcCtD
Ethambutol—Erythema multiforme—Vemurafenib—skin cancer	0.00864	0.00864	CcSEcCtD
Ethambutol—Stevens-Johnson syndrome—Imiquimod—skin cancer	0.0086	0.0086	CcSEcCtD
Ethambutol—Gastrointestinal pain—Vismodegib—skin cancer	0.00859	0.00859	CcSEcCtD
Ethambutol—Neuropathy peripheral—Imiquimod—skin cancer	0.00851	0.00851	CcSEcCtD
Ethambutol—Abdominal pain—Vismodegib—skin cancer	0.0083	0.0083	CcSEcCtD
Ethambutol—Neuritis—Docetaxel—skin cancer	0.00828	0.00828	CcSEcCtD
Ethambutol—Scotoma—Docetaxel—skin cancer	0.00814	0.00814	CcSEcCtD
Ethambutol—Visual impairment—Imiquimod—skin cancer	0.00751	0.00751	CcSEcCtD
Ethambutol—Pruritus—Vismodegib—skin cancer	0.00743	0.00743	CcSEcCtD
Ethambutol—Erythema multiforme—Imiquimod—skin cancer	0.00737	0.00737	CcSEcCtD
Ethambutol—Dermatitis exfoliative—Temozolomide—skin cancer	0.00715	0.00715	CcSEcCtD
Ethambutol—Disorientation—Fluorouracil—skin cancer	0.00695	0.00695	CcSEcCtD
Ethambutol—Liver function test abnormal—Dactinomycin—skin cancer	0.00689	0.00689	CcSEcCtD
Ethambutol—Arthralgia—Vemurafenib—skin cancer	0.00677	0.00677	CcSEcCtD
Ethambutol—Toxic epidermal necrolysis—Dactinomycin—skin cancer	0.00672	0.00672	CcSEcCtD
Ethambutol—Vomiting—Vismodegib—skin cancer	0.00668	0.00668	CcSEcCtD
Ethambutol—Rash—Vismodegib—skin cancer	0.00662	0.00662	CcSEcCtD
Ethambutol—Dermatitis—Vismodegib—skin cancer	0.00662	0.00662	CcSEcCtD
Ethambutol—Anaphylactic shock—Vemurafenib—skin cancer	0.00649	0.00649	CcSEcCtD
Ethambutol—Ill-defined disorder—Imiquimod—skin cancer	0.00629	0.00629	CcSEcCtD
Ethambutol—Nausea—Vismodegib—skin cancer	0.00624	0.00624	CcSEcCtD
Ethambutol—Pneumonia—Bleomycin—skin cancer	0.0062	0.0062	CcSEcCtD
Ethambutol—Malaise—Imiquimod—skin cancer	0.00611	0.00611	CcSEcCtD
Ethambutol—Toxic epidermal necrolysis—Temozolomide—skin cancer	0.00608	0.00608	CcSEcCtD
Ethambutol—Neutropenia—Dactinomycin—skin cancer	0.00603	0.00603	CcSEcCtD
Ethambutol—Musculoskeletal discomfort—Vemurafenib—skin cancer	0.00591	0.00591	CcSEcCtD
Ethambutol—Pneumonia—Dactinomycin—skin cancer	0.00578	0.00578	CcSEcCtD
Ethambutol—Arthralgia—Imiquimod—skin cancer	0.00577	0.00577	CcSEcCtD
Ethambutol—Discomfort—Imiquimod—skin cancer	0.0057	0.0057	CcSEcCtD
Ethambutol—Stevens-Johnson syndrome—Dactinomycin—skin cancer	0.0057	0.0057	CcSEcCtD
Ethambutol—Decreased appetite—Vemurafenib—skin cancer	0.00564	0.00564	CcSEcCtD
Ethambutol—Hypoaesthesia—Bleomycin—skin cancer	0.00551	0.00551	CcSEcCtD
Ethambutol—Neutropenia—Temozolomide—skin cancer	0.00545	0.00545	CcSEcCtD
Ethambutol—Eosinophilia—Fluorouracil—skin cancer	0.00532	0.00532	CcSEcCtD
Ethambutol—Anorexia—Imiquimod—skin cancer	0.00528	0.00528	CcSEcCtD
Ethambutol—Pneumonia—Temozolomide—skin cancer	0.00523	0.00523	CcSEcCtD
Ethambutol—Hepatitis—Dactinomycin—skin cancer	0.00516	0.00516	CcSEcCtD
Ethambutol—Stevens-Johnson syndrome—Temozolomide—skin cancer	0.00516	0.00516	CcSEcCtD
Ethambutol—Body temperature increased—Vemurafenib—skin cancer	0.00513	0.00513	CcSEcCtD
Ethambutol—Neuropathy peripheral—Temozolomide—skin cancer	0.0051	0.0051	CcSEcCtD
Ethambutol—Musculoskeletal discomfort—Imiquimod—skin cancer	0.00504	0.00504	CcSEcCtD
Ethambutol—Paraesthesia—Imiquimod—skin cancer	0.00497	0.00497	CcSEcCtD
Ethambutol—Erythema multiforme—Dactinomycin—skin cancer	0.00488	0.00488	CcSEcCtD
Ethambutol—Pneumonia—Fluorouracil—skin cancer	0.00482	0.00482	CcSEcCtD
Ethambutol—Decreased appetite—Imiquimod—skin cancer	0.00481	0.00481	CcSEcCtD
Ethambutol—Hypersensitivity—Vemurafenib—skin cancer	0.00478	0.00478	CcSEcCtD
Ethambutol—Neuropathy peripheral—Fluorouracil—skin cancer	0.0047	0.0047	CcSEcCtD
Ethambutol—Hepatitis—Temozolomide—skin cancer	0.00467	0.00467	CcSEcCtD
Ethambutol—Hallucination—Temozolomide—skin cancer	0.00464	0.00464	CcSEcCtD
Ethambutol—Hypoaesthesia—Temozolomide—skin cancer	0.00464	0.00464	CcSEcCtD
Ethambutol—Pruritus—Vemurafenib—skin cancer	0.00459	0.00459	CcSEcCtD
Ethambutol—Feeling abnormal—Imiquimod—skin cancer	0.00456	0.00456	CcSEcCtD
Ethambutol—Gastrointestinal pain—Imiquimod—skin cancer	0.00453	0.00453	CcSEcCtD
Ethambutol—Visual impairment—Temozolomide—skin cancer	0.0045	0.0045	CcSEcCtD
Ethambutol—Ill-defined disorder—Bleomycin—skin cancer	0.00447	0.00447	CcSEcCtD
Ethambutol—Erythema multiforme—Temozolomide—skin cancer	0.00441	0.00441	CcSEcCtD
Ethambutol—Abdominal pain—Imiquimod—skin cancer	0.00437	0.00437	CcSEcCtD
Ethambutol—Body temperature increased—Imiquimod—skin cancer	0.00437	0.00437	CcSEcCtD
Ethambutol—Malaise—Bleomycin—skin cancer	0.00434	0.00434	CcSEcCtD
Ethambutol—Leukopenia—Bleomycin—skin cancer	0.00431	0.00431	CcSEcCtD
Ethambutol—Dizziness—Vemurafenib—skin cancer	0.00429	0.00429	CcSEcCtD
Ethambutol—Hypoaesthesia—Fluorouracil—skin cancer	0.00428	0.00428	CcSEcCtD
Ethambutol—Ill-defined disorder—Dactinomycin—skin cancer	0.00417	0.00417	CcSEcCtD
Ethambutol—Liver function test abnormal—Docetaxel—skin cancer	0.00414	0.00414	CcSEcCtD
Ethambutol—Vomiting—Vemurafenib—skin cancer	0.00413	0.00413	CcSEcCtD
Ethambutol—Rash—Vemurafenib—skin cancer	0.00409	0.00409	CcSEcCtD
Ethambutol—Dermatitis—Vemurafenib—skin cancer	0.00409	0.00409	CcSEcCtD
Ethambutol—Hypersensitivity—Imiquimod—skin cancer	0.00408	0.00408	CcSEcCtD
Ethambutol—Headache—Vemurafenib—skin cancer	0.00407	0.00407	CcSEcCtD
Ethambutol—Discomfort—Bleomycin—skin cancer	0.00405	0.00405	CcSEcCtD
Ethambutol—Malaise—Dactinomycin—skin cancer	0.00405	0.00405	CcSEcCtD
Ethambutol—Toxic epidermal necrolysis—Docetaxel—skin cancer	0.00404	0.00404	CcSEcCtD
Ethambutol—Leukopenia—Dactinomycin—skin cancer	0.00402	0.00402	CcSEcCtD
Ethambutol—Confusional state—Bleomycin—skin cancer	0.00396	0.00396	CcSEcCtD
Ethambutol—Anaphylactic shock—Bleomycin—skin cancer	0.00393	0.00393	CcSEcCtD
Ethambutol—Pruritus—Imiquimod—skin cancer	0.00392	0.00392	CcSEcCtD
Ethambutol—Nausea—Vemurafenib—skin cancer	0.00385	0.00385	CcSEcCtD
Ethambutol—Thrombocytopenia—Bleomycin—skin cancer	0.00385	0.00385	CcSEcCtD
Ethambutol—Vision blurred—Temozolomide—skin cancer	0.00383	0.00383	CcSEcCtD
Ethambutol—Discomfort—Dactinomycin—skin cancer	0.00378	0.00378	CcSEcCtD
Ethambutol—Ill-defined disorder—Temozolomide—skin cancer	0.00377	0.00377	CcSEcCtD
Ethambutol—Anorexia—Bleomycin—skin cancer	0.00375	0.00375	CcSEcCtD
Ethambutol—Malaise—Temozolomide—skin cancer	0.00366	0.00366	CcSEcCtD
Ethambutol—Dizziness—Imiquimod—skin cancer	0.00366	0.00366	CcSEcCtD
Ethambutol—Leukopenia—Temozolomide—skin cancer	0.00364	0.00364	CcSEcCtD
Ethambutol—Neutropenia—Docetaxel—skin cancer	0.00363	0.00363	CcSEcCtD
Ethambutol—Thrombocytopenia—Dactinomycin—skin cancer	0.00359	0.00359	CcSEcCtD
Ethambutol—Musculoskeletal discomfort—Bleomycin—skin cancer	0.00358	0.00358	CcSEcCtD
Ethambutol—Paraesthesia—Bleomycin—skin cancer	0.00353	0.00353	CcSEcCtD
Ethambutol—Vision blurred—Fluorouracil—skin cancer	0.00353	0.00353	CcSEcCtD
Ethambutol—Vomiting—Imiquimod—skin cancer	0.00352	0.00352	CcSEcCtD
Ethambutol—Anorexia—Dactinomycin—skin cancer	0.0035	0.0035	CcSEcCtD
Ethambutol—Rash—Imiquimod—skin cancer	0.00349	0.00349	CcSEcCtD
Ethambutol—Dermatitis—Imiquimod—skin cancer	0.00349	0.00349	CcSEcCtD
Ethambutol—Pneumonia—Docetaxel—skin cancer	0.00348	0.00348	CcSEcCtD
Ethambutol—Headache—Imiquimod—skin cancer	0.00347	0.00347	CcSEcCtD
Ethambutol—Arthralgia—Temozolomide—skin cancer	0.00346	0.00346	CcSEcCtD
Ethambutol—Stevens-Johnson syndrome—Docetaxel—skin cancer	0.00343	0.00343	CcSEcCtD
Ethambutol—Discomfort—Temozolomide—skin cancer	0.00342	0.00342	CcSEcCtD
Ethambutol—Decreased appetite—Bleomycin—skin cancer	0.00342	0.00342	CcSEcCtD
Ethambutol—Neuropathy peripheral—Docetaxel—skin cancer	0.00339	0.00339	CcSEcCtD
Ethambutol—Leukopenia—Fluorouracil—skin cancer	0.00335	0.00335	CcSEcCtD
Ethambutol—Confusional state—Temozolomide—skin cancer	0.00334	0.00334	CcSEcCtD
Ethambutol—Musculoskeletal discomfort—Dactinomycin—skin cancer	0.00334	0.00334	CcSEcCtD
Ethambutol—Anaphylactic shock—Temozolomide—skin cancer	0.00332	0.00332	CcSEcCtD
Ethambutol—Nausea—Imiquimod—skin cancer	0.00329	0.00329	CcSEcCtD
Ethambutol—Thrombocytopenia—Temozolomide—skin cancer	0.00325	0.00325	CcSEcCtD
Ethambutol—Feeling abnormal—Bleomycin—skin cancer	0.00324	0.00324	CcSEcCtD
Ethambutol—Decreased appetite—Dactinomycin—skin cancer	0.00319	0.00319	CcSEcCtD
Ethambutol—Anorexia—Temozolomide—skin cancer	0.00316	0.00316	CcSEcCtD
Ethambutol—Discomfort—Fluorouracil—skin cancer	0.00315	0.00315	CcSEcCtD
Ethambutol—Body temperature increased—Bleomycin—skin cancer	0.00311	0.00311	CcSEcCtD
Ethambutol—Hepatitis—Docetaxel—skin cancer	0.0031	0.0031	CcSEcCtD
Ethambutol—Hypoaesthesia—Docetaxel—skin cancer	0.00309	0.00309	CcSEcCtD
Ethambutol—Confusional state—Fluorouracil—skin cancer	0.00308	0.00308	CcSEcCtD
Ethambutol—Anaphylactic shock—Fluorouracil—skin cancer	0.00306	0.00306	CcSEcCtD
Ethambutol—Feeling abnormal—Dactinomycin—skin cancer	0.00302	0.00302	CcSEcCtD
Ethambutol—Musculoskeletal discomfort—Temozolomide—skin cancer	0.00302	0.00302	CcSEcCtD
Ethambutol—Gastrointestinal pain—Dactinomycin—skin cancer	0.003	0.003	CcSEcCtD
Ethambutol—Thrombocytopenia—Fluorouracil—skin cancer	0.00299	0.00299	CcSEcCtD
Ethambutol—Visual impairment—Docetaxel—skin cancer	0.00299	0.00299	CcSEcCtD
Ethambutol—Paraesthesia—Temozolomide—skin cancer	0.00298	0.00298	CcSEcCtD
Ethambutol—Erythema multiforme—Docetaxel—skin cancer	0.00294	0.00294	CcSEcCtD
Ethambutol—Anorexia—Fluorouracil—skin cancer	0.00291	0.00291	CcSEcCtD
Ethambutol—Abdominal pain—Dactinomycin—skin cancer	0.0029	0.0029	CcSEcCtD
Ethambutol—Body temperature increased—Dactinomycin—skin cancer	0.0029	0.0029	CcSEcCtD
Ethambutol—Hypersensitivity—Bleomycin—skin cancer	0.0029	0.0029	CcSEcCtD
Ethambutol—Decreased appetite—Temozolomide—skin cancer	0.00288	0.00288	CcSEcCtD
Ethambutol—Musculoskeletal discomfort—Fluorouracil—skin cancer	0.00278	0.00278	CcSEcCtD
Ethambutol—Pruritus—Bleomycin—skin cancer	0.00278	0.00278	CcSEcCtD
Ethambutol—Paraesthesia—Fluorouracil—skin cancer	0.00274	0.00274	CcSEcCtD
Ethambutol—Feeling abnormal—Temozolomide—skin cancer	0.00273	0.00273	CcSEcCtD
Ethambutol—Gastrointestinal pain—Temozolomide—skin cancer	0.00271	0.00271	CcSEcCtD
Ethambutol—Hypersensitivity—Dactinomycin—skin cancer	0.0027	0.0027	CcSEcCtD
Ethambutol—Decreased appetite—Fluorouracil—skin cancer	0.00266	0.00266	CcSEcCtD
Ethambutol—Abdominal pain—Temozolomide—skin cancer	0.00262	0.00262	CcSEcCtD
Ethambutol—Body temperature increased—Temozolomide—skin cancer	0.00262	0.00262	CcSEcCtD
Ethambutol—Feeling abnormal—Fluorouracil—skin cancer	0.00252	0.00252	CcSEcCtD
Ethambutol—Vomiting—Bleomycin—skin cancer	0.0025	0.0025	CcSEcCtD
Ethambutol—Rash—Bleomycin—skin cancer	0.00248	0.00248	CcSEcCtD
Ethambutol—Dermatitis—Bleomycin—skin cancer	0.00248	0.00248	CcSEcCtD
Ethambutol—Hypersensitivity—Temozolomide—skin cancer	0.00244	0.00244	CcSEcCtD
Ethambutol—Leukopenia—Docetaxel—skin cancer	0.00242	0.00242	CcSEcCtD
Ethambutol—Body temperature increased—Fluorouracil—skin cancer	0.00242	0.00242	CcSEcCtD
Ethambutol—Pruritus—Temozolomide—skin cancer	0.00235	0.00235	CcSEcCtD
Ethambutol—Nausea—Bleomycin—skin cancer	0.00234	0.00234	CcSEcCtD
Ethambutol—Vomiting—Dactinomycin—skin cancer	0.00233	0.00233	CcSEcCtD
Ethambutol—Rash—Dactinomycin—skin cancer	0.00231	0.00231	CcSEcCtD
Ethambutol—Arthralgia—Docetaxel—skin cancer	0.0023	0.0023	CcSEcCtD
Ethambutol—Hypersensitivity—Fluorouracil—skin cancer	0.00225	0.00225	CcSEcCtD
Ethambutol—Confusional state—Docetaxel—skin cancer	0.00222	0.00222	CcSEcCtD
Ethambutol—Anaphylactic shock—Docetaxel—skin cancer	0.00221	0.00221	CcSEcCtD
Ethambutol—Dizziness—Temozolomide—skin cancer	0.00219	0.00219	CcSEcCtD
Ethambutol—Nausea—Dactinomycin—skin cancer	0.00218	0.00218	CcSEcCtD
Ethambutol—Pruritus—Fluorouracil—skin cancer	0.00216	0.00216	CcSEcCtD
Ethambutol—Thrombocytopenia—Docetaxel—skin cancer	0.00216	0.00216	CcSEcCtD
Ethambutol—Vomiting—Temozolomide—skin cancer	0.00211	0.00211	CcSEcCtD
Ethambutol—Anorexia—Docetaxel—skin cancer	0.0021	0.0021	CcSEcCtD
Ethambutol—Rash—Temozolomide—skin cancer	0.00209	0.00209	CcSEcCtD
Ethambutol—Dermatitis—Temozolomide—skin cancer	0.00209	0.00209	CcSEcCtD
Ethambutol—Headache—Temozolomide—skin cancer	0.00208	0.00208	CcSEcCtD
Ethambutol—Dizziness—Fluorouracil—skin cancer	0.00202	0.00202	CcSEcCtD
Ethambutol—Musculoskeletal discomfort—Docetaxel—skin cancer	0.00201	0.00201	CcSEcCtD
Ethambutol—Paraesthesia—Docetaxel—skin cancer	0.00198	0.00198	CcSEcCtD
Ethambutol—Nausea—Temozolomide—skin cancer	0.00197	0.00197	CcSEcCtD
Ethambutol—Vomiting—Fluorouracil—skin cancer	0.00194	0.00194	CcSEcCtD
Ethambutol—Rash—Fluorouracil—skin cancer	0.00193	0.00193	CcSEcCtD
Ethambutol—Dermatitis—Fluorouracil—skin cancer	0.00192	0.00192	CcSEcCtD
Ethambutol—Decreased appetite—Docetaxel—skin cancer	0.00192	0.00192	CcSEcCtD
Ethambutol—Headache—Fluorouracil—skin cancer	0.00191	0.00191	CcSEcCtD
Ethambutol—Feeling abnormal—Docetaxel—skin cancer	0.00182	0.00182	CcSEcCtD
Ethambutol—Nausea—Fluorouracil—skin cancer	0.00182	0.00182	CcSEcCtD
Ethambutol—Gastrointestinal pain—Docetaxel—skin cancer	0.0018	0.0018	CcSEcCtD
Ethambutol—Abdominal pain—Docetaxel—skin cancer	0.00174	0.00174	CcSEcCtD
Ethambutol—Body temperature increased—Docetaxel—skin cancer	0.00174	0.00174	CcSEcCtD
Ethambutol—Hypersensitivity—Docetaxel—skin cancer	0.00162	0.00162	CcSEcCtD
Ethambutol—Pruritus—Docetaxel—skin cancer	0.00156	0.00156	CcSEcCtD
Ethambutol—Dizziness—Docetaxel—skin cancer	0.00146	0.00146	CcSEcCtD
Ethambutol—Vomiting—Docetaxel—skin cancer	0.0014	0.0014	CcSEcCtD
Ethambutol—Rash—Docetaxel—skin cancer	0.00139	0.00139	CcSEcCtD
Ethambutol—Dermatitis—Docetaxel—skin cancer	0.00139	0.00139	CcSEcCtD
Ethambutol—Headache—Docetaxel—skin cancer	0.00138	0.00138	CcSEcCtD
Ethambutol—Nausea—Docetaxel—skin cancer	0.00131	0.00131	CcSEcCtD
